Abbott Laboratories (ABT)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Dec 20, 2012)8-K (Nov 30, 2012)8-K (Nov 28, 2012)8-K (Nov 15, 2012)8-K (Oct 18, 2012)8-K (Oct 17, 2012)8-K (Jul 18, 2012)8-K (Jul 13, 2012)8-K (Jun 1, 2012)8-K (May 2, 2012)8-K (May 1, 2012)8-K (Apr 18, 2012)8-K (Feb 24, 2012)8-K (Jan 25, 2012)8-K (Dec 14, 2011)8-K (Oct 26, 2011)8-K (Oct 20, 2011)8-K (Oct 19, 2011)8-K (Jul 20, 2011)8-K (Jun 16, 2011)8-K (May 5, 2011)8-K (Apr 20, 2011)8-K (Feb 22, 2011)8-K (Jan 26, 2011)8-K (Jan 14, 2011)8-K (Jan 13, 2011)8-K (Oct 20, 2010)8-K (Oct 8, 2010)8-K (Sep 22, 2010)8-K (Sep 21, 2010)8-K (Sep 8, 2010)8-K (Jul 21, 2010)8-K (Jul 1, 2010)8-K (Jun 17, 2010)8-K (May 27, 2010)8-K (May 21, 2010)8-K (Apr 29, 2010)8-K (Apr 21, 2010)8-K (Feb 22, 2010)8-K (Feb 16, 2010)8-K (Jan 27, 2010)8-K (Nov 30, 2009)8-K (Oct 14, 2009)8-K (Sep 28, 2009)8-K (Jul 15, 2009)8-K (Jul 6, 2009)8-K (Apr 24, 2009)8-K (Apr 15, 2009)8-K (Mar 3, 2009)8-K (Feb 23, 2009)8-K (Jan 21, 2009)8-K (Jan 15, 2009)8-K (Jan 12, 2009)8-K (Nov 20, 2008)8-K (Oct 17, 2008)8-K (Oct 16, 2008)8-K (Oct 15, 2008)8-K (Sep 4, 2008)8-K (Aug 21, 2008)8-K (Jul 16, 2008)8-K (Apr 16, 2008)8-K (Mar 24, 2008)8-K (Jan 23, 2008)8-K (Dec 20, 2007)8-K (Nov 9, 2007)8-K (Oct 17, 2007)8-K (Sep 19, 2007)8-K (Aug 3, 2007)8-K (Jul 18, 2007)8-K (Jul 12, 2007)8-K (Jun 29, 2007)8-K (Apr 18, 2007)8-K (Mar 5, 2007)8-K (Feb 20, 2007)8-K (Jan 24, 2007)8-K (Dec 13, 2006)8-K (Nov 9, 2006)8-K (Oct 18, 2006)8-K (Oct 13, 2006)8-K (Jul 19, 2006)8-K (May 11, 2006)8-K (Apr 27, 2006)8-K (Apr 21, 2006)8-K (Apr 19, 2006)8-K (Mar 29, 2006)8-K (Mar 21, 2006)8-K (Feb 21, 2006)8-K (Feb 17, 2006)8-K (Jan 25, 2006)8-K (Jan 20, 2006)8-K (Jan 11, 2006)8-K (Dec 12, 2005)8-K (Nov 30, 2005)8-K (Oct 19, 2005)8-K (Oct 18, 2005)8-K (Oct 17, 2005)8-K (Oct 14, 2005)8-K (Sep 23, 2005)8-K (Aug 31, 2005)8-K (Aug 1, 2005)8-K (Jul 13, 2005)8-K (Jun 23, 2005)8-K (Apr 27, 2005)8-K (Apr 12, 2005)8-K (Apr 5, 2005)8-K (Mar 29, 2005)8-K (Feb 25, 2005)8-K (Jan 31, 2005)8-K (Jan 18, 2005)8-K (Dec 15, 2004)8-K (Oct 15, 2004)8-K (Oct 14, 2004)8-K (Aug 20, 2004)8-K (Jul 9, 2004)8-K (Jul 1, 2004)8-K (Apr 8, 2004)8-K (Apr 6, 2004)8-K (Jan 16, 2004)8-K (Oct 9, 2003)8-K (Aug 22, 2003)8-K (Jul 10, 2003)8-K (Apr 9, 2003)8-K (Aug 13, 2002)8-K (May 2, 2002)8-K (Apr 1, 2002)8-K (Mar 21, 2002)8-K (May 14, 2001)8-K (Apr 20, 2001)8-K (Mar 16, 2001)8-K (Jan 18, 2001)8-K (Dec 18, 2000)8-K (May 19, 2000)8-K (Dec 20, 1999)8-K (Nov 15, 1999)8-K (Nov 10, 1999)8-K (Nov 5, 1999)8-K (Sep 30, 1999)8-K (Jun 30, 1999)

Other

Abbott Laboratories 8-K 2009

Documents found in this filing:

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

February 20, 2009

Date of Report (Date of earliest event reported)

ABBOTT LABORATORIES

(Exact name of registrant as specified in its charter)

Illinois	1-2189	36-0698440
(State or other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

100 Abbott Park Road

Abbott Park, Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 937-6100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year

On February 20, 2009, Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s by-laws to provide that Abbott’s Board of Directors shall consist of thirteen persons, effective as of April 24, 2009. Abbott’s by-laws previously provided that the Board of Directors consisted of fourteen persons.

On February 20, 2009, Abbott’s Board of Directors also amended Article IV, Section 1 of Abbott’s by-laws to provide that each committee of Abbott’s Board of Directors shall have one or more members, effective as of February 20, 2009. Abbott’s by-laws previously required each committee of the Board of Directors to have three or more members.

Item 9.01	Financial Statements and Exhibits

Exhibit No.		Exhibit

3.1		By-Laws of Abbott Laboratories, as amended and restated effective as of April 24, 2009.

3.2		By-Laws of Abbott Laboratories, as amended and restated effective as of February 20, 2009.

10.1		Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section 10 of the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.2		Form of Performance Restricted Stock Agreement for an award of performance restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.3		Form of Non-Qualified Stock Option Agreement for an award of non-qualified stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.4		Form of Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.5		Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009 (ratable vesting).

10.6		Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009 (cliff vesting).

10.7		Form of Restricted Stock Unit Agreement for an award of restricted stock units under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.8		Form of Non-Employee Director Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ABBOTT LABORATORIES


Date: February 23, 2009	By:	/s/ Thomas C. Freyman
		Thomas C. Freyman
		Executive Vice President, Finance
		and Chief Financial Officer

EXHIBIT INDEX

Exhibit No.		Exhibit

3.1		By-Laws of Abbott Laboratories, as amended and restated effective as of April 24, 2009.

3.2		By-Laws of Abbott Laboratories, as amended and restated effective as of February 20, 2009.

10.1		Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section 10 of the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.2		Form of Performance Restricted Stock Agreement for an award of performance restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.3		Form of Non-Qualified Stock Option Agreement for an award of non-qualified stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.4		Form of Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.5		Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009 (ratable vesting).

10.6		Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009 (cliff vesting).

10.7		Form of Restricted Stock Unit Agreement for an award of restricted stock units under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

10.8		Form of Non-Employee Director Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February 20, 2009.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Abbott Laboratories (ABT)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing:

Illinois

1-2189

36-0698440